NEW YORK (GenomeWeb) – Advanced Cell Diagnostics today announced the formation of a European subsidiary, to be operational next month.
The company, which is based in Hayward, Calif., said that the subsidiary has a warehouse and distribution center located close to Milan, Italy and sales, marketing, and technical support staff in Germany and the UK. Today's announcement comes shortly after ACD said that its probe library has grown to more than 4,000 probes.
ACD's flagship RNAscope technology is based on in situ RNA detection. The assays have been available for research use only, but the company plans to launch assays for the clinical diagnostics space before the end of the year with an initial focus on human papillomavirus and head-and-neck cancer.
"Establishing a local subsidiary is a natural next step for us to extend our market presence and provide a faster and enhanced level of service to our customers here," ACD Chief Operating Officer Steve Chen said in a statement.